Hjem › Ægstockræft › Illinois
Ægstockræft kliniske forsøg i Illinois
49 studier for Ægstockræft søger deltagere på steder i Illinois.
Byer i Illinois
- Chicago36 studier
- Peoria7 studier
- Evanston7 studier
- Waukegan6 studier
- Cicero6 studier
- Aurora5 studier
- Arlington Heights5 studier
- Joliet4 studier
- Champaign4 studier
- Springfield4 studier
- Naperville4 studier
- Decatur3 studier
- Bloomington3 studier
- Danville3 studier
- Charleston3 studier
- Elgin3 studier
Officiel studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Advocate Good Shepherd Hospital, Barrington
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- og 57 flere
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 2. okt. 2026 · NCT05564377A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06465069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- University of Chicago Medical Center /ID# 278295, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07278336A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Rush Md Anderson Cancer Center /ID# 274926, Chicago
- University of Chicago Medical Center /ID# 274796, Chicago
- OSF St. Francis Medical Center /ID# 274752, Peoria
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 29. sep. 2026 · NCT06890338Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- University of Chicago, Chicago
RekruttererObservationsstudie
Alder 18 og opefter · Kvinder · Opdateret 29. sep. 2026 · NCT05051722DESTINY-PANTUMOUR04
- Research Site, Decatur
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
RekruttererFase 1/2
Alder 18 og opefter · Kvinder · Opdateret 24. sep. 2026 · NCT04590326A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Illinois Cancer Specialists, Arlington Heights
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Northwestern University Feinberg School of Medicine, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05983432A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Chicago, Zion
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07109726A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Illinois Cancer Specialists (ICS) ( Site 8009), Arlington Heights
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 17. sep. 2026 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- The University of Chicago Medicine, Chicago
- Carle Cancer Center, Effingham
- Northshore University Health System-Evanston Hospital, Evanston
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 15. sep. 2026 · NCT07214779Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- University of Chicago, Chicago
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 14. sep. 2026 · NCT06787612Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
- City of Hope - Chicago, Zion
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06293898Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- University of Chicago, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04107077Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- University of Chicago Medical Center, Chicago
RekruttererFase 1
Alder 15 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
- og 5 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07001748A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- St. Francis Medical Center (OSF Healthcare), Peoria
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07470853A Study of PHST001 in Advanced Solid Tumors
- University of Chicago Medical Center, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT06840886Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
RekruttererFase 1/2
Alder 18 til 130 · Alle køn · Opdateret 12. aug. 2026 · NCT05417594A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Carle BroMenn Outpatient Center, Bloomington
- og 35 flere
Rekrutterer
Alder 35 til 50 · Kvinder · Opdateret 7. aug. 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- og 58 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- St. Francis Medical Center (OSF Healthcare), Peoria
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07444814A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT06330064A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Hope and Healing Cancer Services, Hinsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT04657068A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
- Rush University Medical Center, Chicago
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 23. jul. 2026 · NCT03854110Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
- The University of Chicago Medical Center, Chicago
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 21. jul. 2026 · NCT04918186An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- Northwestern Memorial Hospital, Chicago
RekruttererFase 2
Alder 18 til 100 · Kvinder · Opdateret 13. jul. 2026 · NCT05887609A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- og 13 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. jul. 2026 · NCT04389632Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Endeavor Health Evanston Kellogg Cancer Care Center, Evanston
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 2. jul. 2026 · NCT06819007Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Northwestern University, Chicago
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05377996A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- GSK Investigational Site, Harvey
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT04641247A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Northwestern Memorial Hospital, Chicago
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT04300556Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
- Northwestern University, Chicago
Rekrutterer
Alder 60 og opefter · Kvinder · Opdateret 29. maj 2026 · NCT05743517Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
- OSF Saint Francis Medical Center, Peoria
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 28. maj 2026 · NCT06930755ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Chicago Medical Center, Chicago
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT03686124TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- UChicago Medicine, Chicago
Rekrutterer
Alder 25 til 50 · Kvinder · Opdateret 6. apr. 2026 · NCT04294927Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.